Loading organizations...
Loading organizations...
Global specialty therapeutics business for cancer and infectious diseases.
Ascletis has raised $222.2M across 4 funding rounds.
Key people at Ascletis.
Ascletis was founded by Jinzi Wu (Founder & President , CEO).
Ascletis has raised $222.2M in total across 4 funding rounds.
Ascletis was founded by Jinzi Wu (Founder & President , CEO).
Ascletis has raised $222.2M in total across 4 funding rounds.
Ascletis's investors include C-Bridge Capital, FOCUS Media Jiangnanchun Foundation, Goldman Sachs, Tasly Pharmaceutical, WTT Investment, Hangzhou National Hi-Tech Industrial Development Zone, Hangzhou Binjiang Investment Holding.
Key people at Ascletis.
Ascletis has raised $222.2M across 4 funding rounds. Most recently, it raised $100.6M Series B in January 2017.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 12, 2021 | 3-V Biosciences | $80.0M Other Equity | — | Altium Capital, HM Capital, Invus, Beth Seidenberg, Matt McAviney, PFM Health Sciences, Rock Springs Capital |
| Aug 5, 2019 | 3-V Biosciences | $7.0M Series E Extension | Ascletis | Kleiner Perkins, New Enterprise Associates |
| Feb 13, 2019 | 3-V Biosciences | $18.0M Series E | Jinzi Wu | Beth Seidenberg, New Enterprise Associates, Qianhai Ark (Cayman) Investment |
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 3, 2017 | $100.6M Series B | C-Bridge Capital | FOCUS Media Jiangnanchun Foundation, Goldman Sachs, Tasly Pharmaceutical, WTT Investment |
| Dec 2, 2015 | $20.0M Other Equity | Goldman Sachs | |
| Jan 4, 2012 | $1.6M Grant | Hangzhou National Hi-Tech Industrial Development Zone | |
| Apr 6, 2011 | $100.0M Series A | Hangzhou Binjiang Investment Holding |